Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
FUNDING PROGRAM FOR NEXT GENERATION WORLD-LEADING RESEARCHERS Project Title: Control and Analysis of Cells by Synthetic Small Molecules Name: Motonari UESUGI Institution: Kyoto University 1. Background of research In human history, bioactive small molecules have had three primary uses: as medicines, agrochemicals, and biological tools. This research proposes another application of small molecules: small molecule tools for cell therapy. Although small molecule drugs will continue to be important, cell therapy will be a powerful approach to curing difficult diseases that small molecule drugs are unable to cure. 2. Research objectives The goal of this research is to explore a new way to use small molecules: development of small molecules for cell therapy. To achieve this challenging goal, we need to chemically synthesize small molecules that manipulate fundamental characteristics of human cells. As biological processes all stem from chemical events, it should be possible to understand or manipulate biological events by using chemistry. 3. Research characteristics (incl. originality and creativity) This research integrates chemistry and cell therapy, two of the prominent fields that are strongly represented in Japan. By combining the cutting-edge techniques of chemistry and those of biology, we may be able to generate a series of unique small molecules that we have never seen before. These unexplored types of small molecules may benefit us in both basic cell biology research and cell therapy application. 4. Anticipated effects and future applications of research In near future, cell therapy will be more common treatment in clinics. One of the remaining problems is its high cost. Mass-production of low-cost, stable, and defined small molecule tools for cell therapy would be able to reduce the cost and might also improve the safety of cell therapy.